Prognostic Value of HALP Score in Rheumatic Mitral Stenosis: A Long-Term Follow-up Study

Ahmet Ferhat Kaya1, Görkem Ayhan1, Veysi Can

  • 1Department of Cardiology, Van Regional Education and Research Hospital, Van, Turkey.

Clinical Cardiology
|March 27, 2026
PubMed

Insights

The hemoglobin-albumin-lymphocyte-platelet (HALP) score shows modest prognostic value for major adverse cardiac and cerebrovascular events (MACCE) in rheumatic mitral stenosis (RMS) patients. It is a useful complementary tool but not an independent predictor alone.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Biomarkers

Background:

  • Rheumatic mitral stenosis (RMS) requires accurate prognostic tools for patient management.
  • The hemoglobin-albumin-lymphocyte-platelet (HALP) score is a composite biomarker with potential prognostic implications.

Purpose of the Study:

  • To investigate the prognostic value of the HALP score in predicting major adverse cardiac and cerebrovascular events (MACCE) in patients with RMS.

Main Methods:

  • Retrospective analysis of 169 RMS patients with a median follow-up of 124 months.
  • Assessment of HALP score's predictive performance using ROC analysis, Cox regression, and Kaplan-Meier survival analysis.
  • Primary endpoint defined as MACCE.

Main Results:

  • The HALP score demonstrated a statistically significant, albeit modest, ability to predict MACCE (AUC=0.644, p=0.037).
  • Lower HALP scores were associated with a significantly higher incidence of MACCE (log-rank p=0.015).
  • The HALP score was not an independent predictor in multivariable analysis (p=0.076).

Conclusions:

  • The HALP score can serve as a simple, cost-effective complementary tool for risk stratification in RMS patients.
  • Its prognostic value is limited when used in isolation.
  • Interpretation alongside established clinical and echocardiographic parameters is recommended.
Abstract

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
440
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
368
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.3K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
456
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.1K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.0K